Dan Xu
Impact in
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Aging top 2%
Papers in
-
- Circular RNAs in diseases 15
- RNA modifications and cancer 14
-
- Cancer-related molecular mechanisms research 27
- MicroRNA in disease regulation 22
- Co-authors
- Fuqiang Wen (37 shared papers)Ling Zhang (4 shared papers)Fu Yang (4 shared papers)Ji‐hang Yuan (4 shared papers)Shuhan Sun (4 shared papers)Hidetoshi Tahara (4 shared papers)Tao Wang (24 shared papers)Xisong Huo (2 shared papers)
- Journals
- International Immunopharmacology (10 papers)Biochemical and Biophysical Research Communications (5 papers)Acta Pharmacologica Sinica (5 papers)Ecotoxicology and Environmental Safety (5 papers)European Respiratory Journal (3 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Dan Xu
217 papers receiving 5.0k citations
Dan Xu's Hit Papers
Peers
Comparison fields: 5 of 144
- Cancer Research 1.8k
- Aging 96
- Molecular Biology 2.8k
- Immunology 515
- Physiology 513
Countries citing papers authored by Dan Xu
This map shows the geographic impact of Dan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Xu more than expected).
Fields of papers citing papers by Dan Xu
This network shows the impact of papers produced by Dan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Xu. The network helps show where Dan Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Dan Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 234 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans Hit paper breakdown → | 2011 | 563 |
| 2 | 2012 | 295 | |
| 3 | 2011 | 259 | |
| 4 | 2013 | 165 | |
| 5 | 2012 | 131 | |
| 6 | 2021 | 121 | |
| 7 | 2021 | 119 | |
| 8 | 2012 | 117 | |
| 9 | 2016 | 103 | |
| 10 | 2015 | 86 | |
| 11 | 2019 | 84 | |
| 12 | 2008 | 64 | |
| 13 | 2014 | 64 | |
| 14 | 2020 | 59 | |
| 15 | 2009 | 58 | |
| 16 | 2016 | 57 | |
| 17 | 2020 | 55 | |
| 18 | 2017 | 51 | |
| 19 | 2012 | 51 | |
| 20 | 2012 | 50 |
About Dan Xu
Dan Xu is a scholar working on Molecular Biology, Cancer Research, Physiology, Pulmonary and Respiratory Medicine and Immunology, having authored 234 papers that have together received 5.1k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (27 papers), MicroRNA in disease regulation (22 papers), Circular RNAs in diseases (15 papers), RNA modifications and cancer (14 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (11 papers), Adipose Tissue and Metabolism (10 papers), Genetics, Aging, and Longevity in Model Organisms (9 papers) and Autophagy in Disease and Therapy (8 papers). The work is most often cited by research in Cancer Research (1.8k citations), Aging (96 citations), Molecular Biology (2.8k citations), Immunology (515 citations) and Physiology (513 citations). Dan Xu has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Fuqiang Wen, Ling Zhang, Fu Yang, Ji‐hang Yuan, Shuhan Sun, Hidetoshi Tahara, Tao Wang, Xisong Huo, Weiping Zhou and Shengxian Yuan. Their work appears in journals such as International Immunopharmacology, Biochemical and Biophysical Research Communications, Acta Pharmacologica Sinica, Ecotoxicology and Environmental Safety and European Respiratory Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.